Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers
13 avr. 2022 08h30 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the...
Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer
28 mars 2022 08h30 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the...